Smith+Nephew (SNN): Growth-Adjusted P/E Ratio

Brandmark of Smith & Nephew plc (SNN)

Smith & Nephew plc (SNN) relies on inelastic demand in joint therapy and innovations in sports medicine. The PEG momentum indicator provided by GURU.Markets demonstrates the current valuation trajectory, where the indicator level stands at 1.70. The development of digital surgery is progressing through robotics partnerships, while stringent regulatory barriers and clinic loyalty protect the company's market share.

SNN Smith & Nephew plc Price/Earnings to Growth Ratio (07/04/2022 - 11/12/2026)

Metric breakdowns and analytics for Smith & Nephew plc (SNN)

- stock value and consensus price forecast:
Stock Price Smith & Nephew PLC|SNN - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Smith & Nephew Corp|SNN - Enterprise Value
- business book valuation details:
Net Asset Value per Share Smith & Nephew|SNN - Company Book Value|Market-to-Book Ratio smith-nephew.com|SNN - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Smith & Nephew plc|SNN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient smith-nephew.com|SNN - Company Total Debt|Debt to Net Assets Ratio Smith & Nephew Corp|SNN - Company Long-Term Debt|Company Current Liabilities Smith & Nephew|Immediate Liquidity smith-nephew.com
- earnings and multiples data:
SNN - Net Profit|Net Profit Forecast Smith & Nephew plc|SNN - P/E Multiple|Market Cap to Projected Earnings Smith+Nephew|SNN - PEG Multiple|Enterprise Value to EBITDA Ratio Smith & Nephew Corp|SNN - Operating profit EBITDA|Net earnings per share (EPS TTM) Smith & Nephew|SNN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months smith-nephew.com|SNN - Net earnings per share growth this year|Expected earnings per share trend next year Smith & Nephew plc
Summary company analytics:Smith & Nephew PLC, SNN
Signature product of Smith & Nephew

The PEG ratio assesses the balance between market value and earnings growth rates, where a value below one signals a fundamental undervaluation of the asset. By analyzing the price-to-earnings ratio relative to EPS growth, an investor can evaluate the extent to which the capitalization of Smith & Nephew plc (SNN) is justified by the recovery of its US implant market share and the volume of orthopedic surgeries amid production risks.

Competitors of Smith & Nephew plc

PEG Multiple Stryker Corp (SYK)|Price/Earnings to Growth Ratio Medtronic PLC MDT|PHG: Growth-Adjusted P/E Ratio|Hologic, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate carlisle.com|Integer (ITGR) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate LivaNova plc (LIVN)|Price/Earnings to Growth Multiple AHCO|PEG Multiple ssinnovations.com|Price/Earnings to Growth Ratio Avanos Medical, Inc. (AVNS)|Growth-Adjusted Market Cap to Net Income shoulderinnovations.com|Viemed - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio INGN|OWLT - Price/Earnings to Growth Ratio|Quipt (QIPT) - Price/Earnings to Growth Multiple|POCI: PEG Multiple|Price to Earnings Adjusted for Growth Rate PAVmed (PAVM)|TIVC (Tivic Health) - PEG Multiple|Growth-Adjusted P/E Ratio MOVE (Movano Health)|PEG Multiple NUVO